Neutrophil hypersegmentation in children receiving angiotensin converting enzyme inhibitors
Vedat Okutan1, A Emin Kürekçi, S Umit Sarici
1Department of Pediatrics, Gülhane Military Medical Academy, Ankara, Turkey.
Insights
Angiotensin converting enzyme inhibitors, like captopril and enalapril, were linked to neutrophil hypersegmentation in children with heart disease. This previously unreported finding suggests a potential impact on the hematopoietic system from these common cardiac medications.
Area of Science:
- Pediatric Cardiology
- Hematology
- Pharmacology
Background:
- Angiotensin converting enzyme (ACE) inhibitors are widely used for pediatric cardiac conditions.
- The bone marrow's renin-angiotensin system may influence hematopoietic processes.
- A potential link between ACE inhibition and hematopoietic changes, specifically granulocyte morphology, was hypothesized.
Purpose of the Study:
- To prospectively investigate the effect of ACE inhibitors on neutrophil morphology, particularly segmentation, in children.
- To compare neutrophil morphology in children with cardiac disease on ACE inhibitors versus healthy controls.
Main Methods:
- A prospective study involving 40 children (2-16 years) on ACE inhibitors (captopril or enalapril) and 40 age/sex-matched healthy controls.
- Comprehensive blood tests including complete blood count and peripheral blood smear analysis.
- Blinded evaluation of peripheral blood smears by pediatric hematologists to assess neutrophil segmentation.
Main Results:
- Significantly higher incidence of neutrophil hypersegmentation in the ACE inhibitor group compared to controls.
- Mean neutrophil lobe count was significantly elevated in children receiving ACE inhibitors.
- Neutrophil hypersegmentation associated with ACE inhibitor use in children is a novel finding.
Conclusions:
- ACE inhibitor use in children with cardiac disease is associated with neutrophil hypersegmentation.
- The underlying pathophysiological mechanisms require further investigation.
- This finding highlights a potential, previously unrecognized effect of ACE inhibitors on the hematopoietic system.
Abstract:
Captopril and enalapril are the most commonly used angiotensin converting enzyme inhibitors in several cardiac diseases in children. On the other hand, the intrinsic renin-angiotensin system in the bone marrow might affect the growth of hematopoietic colonies and cellular production, proliferation and differentiation in physiological and pathological states. Starting with the hypothesis that inhibition of the renin-angiotensin system may have some effects on the hematopoietic system, including morphological changes within the granulocytes, we thus aimed to investigate prospectively whether the use of angiotensin converting enzyme inhibitors has any effect on the morphology, and especially segmentation, of neutrophils in peripheral blood. A total of 40 children with various heart diseases receiving either of two angiotensin converting enzyme inhibitors (captopril or enalapril) aged between 2 to 16 years were enrolled, and 40 healthy age- and sex-matched children were enrolled as controls. Complete blood count, peripheral blood smear, liver and renal function tests, and measurement of serum alkaline phosphatase, ferritin, vitamin B12 and folate levels were performed in all cases. Peripheral blood smears were viewed by two pediatric hematologists in a blinded manner. Neutrophil hypersegmentation was described as presence of five or more neutrophils with five well-separated lobes or at least one neutrophil with six or more lobes among 100 segmented neutrophils. The number of patients with neutrophil hypersegmentation in the study group was significantly higher than in the control group, and the mean lobe count in the study group was significantly higher than in the control group. Neutrophil hypersegmentation, as detected in patients using angiotensin converting enzyme inhibitors in the present study, has not been reported previously. Further studies aiming to explain the pathophysiological mechanism(s) underlying neutrophil hypersegmentation in patients receiving angiotensin converting enzyme inhibitors are needed.
Related Concept Videos
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Nephrotic Syndrome I : Introduction
Acute Pyelonephritis I: Introduction
Pharmacokinetics in Pediatric Patients: Drug Metabolism


